More Nuvo Pharmaceuticals Inc news
NU Nuvo Pharmaceuticals IncTSX: MRV

Nuvo Research® Announces Appointment to its Board of Directors

Nov 3, 2015 at 7:30 AM EST · Issued by Nuvo Pharmaceuticals Inc via CNW

On 6ix: 6ix.com/news/nuvo-researchandxae-announces-appointment-to-its-board-of-directors

Investor Relations, Email: ir@nuvoresearch.comCopyright CNW Group 2015

View original source (CNW)Nuvo Pharmaceuticals Inc on 6ix

Earlier from Nuvo Pharmaceuticals

  • Nuvo Research® Announces Intention to Split Into Two Publicly Traded CompaniesSep 15, 2015
  • Nuvo Research® Announces U.S. Patent for Topical Foamed Formulations that Include DMSOAug 20, 2015
  • Nuvo Research® Announces Grant of United States Patent for Topical Onychomycosis FormulationAug 11, 2015
  • Nuvo Research® Announces 2015 Second Quarter ResultsAug 5, 2015
  • Nuvo Research® Provides Update on International Licensing of Pennsaid® 2%Jun 24, 2015

Later from Nuvo Pharmaceuticals

  • Nuvo Research Announces Successful Pennsaid®2% Phase 3 Trial for RussiaNov 5, 2015
  • Nuvo Research® Announces 2015 Third Quarter ResultsNov 10, 2015
  • Nuvo Research® Announces TSX Conditional Approval to List Crescita Therapeutics Inc.Nov 23, 2015
  • Nuvo Research® Announces Acceleration of Expiry Date of Outstanding WarrantsNov 30, 2015
  • Nuvo Research® Provides Update on Pennsaid® 2% Phase 3 Clinical TrialDec 3, 2015
All Nuvo Pharmaceuticals news releases↗

Follow Nuvo Pharmaceuticals into a list and get an email when it puts out news.

Follow Nuvo Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer